Curapatient
Irvine, US · Founded 2018 · Delaware corporation · 1 known investors
Curapatient (The Claims Genomics Company) builds a pre-payment claims integrity engine that analyzes medical claims by comparing the care documented against what was billed, producing a defensible reimbursement figure with cited provenance. It serves health plans, health systems, and rural/safety-net providers to reduce disputes, audits, and appeals in the healthcare claims and revenue cycle process.
AI & Machine LearningDigital HealthInsurTech
Founders & leadership
TB
Timothy BabichDirector
LN
Long NguyenCo-founder & CEO
CR
Charles RockefellerExecutive Officer, Director
KP
Kevin PethtelExecutive Officer, Director
CR
C. RockefellerCo-founder · capital
DS
Dr. S. MukherjeeCo-founder · physician-scientist
Investors · 1
Competitors · 3
by search overlapCurative11 shared keywords
Elion5 shared keywords
Recuro Health5 shared keywordsRecuro is a virtual-first digital health platform that provides primary care, behavioral health, urgent care, and supplemental benefits (pharmacy, care management, advocacy) to patients, employers, health plans, and providers. The company delivers customizable virtual care solutions designed to improve access, member engagement, and health equity.
Companies competing with Curapatient for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements▶$1.1MraisedAug 2022 · 2 investors · Other TechnologyRule 506(b)
▶$1.1MraisedAug 2022 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles RockefellerExecutive Officer, Director
- Kevin PethtelExecutive Officer
- Long NguyenExecutive Officer, Director
- Timothy BabichDirector
- Amount sold
- $1.1M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$8.2MraisedFeb 2022 · 26 investors · OtherRule 506(b)
▶$8.2MraisedFeb 2022 · 26 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Timothy BabichDirector
- Long NguyenExecutive Officer, Director
- Charles RockefellerExecutive Officer, Director
- Kevin PethtelExecutive Officer, Director
- Offering amount
- $9.2M
- Amount sold
- $8.2M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.